Mark Grayson

The Financial Express published an article on the Free Trade Agreement (FTA) talks that continue between the European Union (EU) and India.

The third-annual Global Funding of Innovation for Neglected Diseases (G-FINDER) survey was released last week revealing both good and bad news

Starting this month, members of Congress will be looking closely at U.S. spending as they work with the White House to build the 2012 budget.

Earlier this week, the United Nations announced a new plan of action designed to help fight disease resistance to artemisinin, the world's most potent treatment for malaria.

According to a Reuter's article, the European Union (EU) and India have come to an agreement which should ease the process of exporting Indian drug manufacturers' medicines

The New England Journal of Medicine recently released the results of a ground-breaking trial of an HIV-prevention method

There is a public health crisis in the least developed countries. It is a crisis made by humans and solvable only by humans

A recent Global Health Progress fact sheet highlights how Mexico's investment in its biopharmaceutical sector has spurred economic growth

Data revealed in Global Health Progress' (GHP) new fact sheet shows that China is projected to become one of the world's major biopharmaceutical players

Global Health Progress (GHP) released a new fact sheet highlighting Russia's commitment to expanding and promoting its biotechnology sector